Lisle, IL – According to filings with the U.S. Securities and Exchange Commission, Endotronix is raising $90,787,992.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Harry Rowland played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Endotronix

Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.

To learn more about Endotronix, visit http://endotronix.com/

Contact:
Harry Rowland, Chief Executive Officer
630-473-3200
harry.rowland@endotronix.com
https://www.linkedin.com/in/harry-rowland-9098504/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved